Immunotherapy
TAU scientists take on battle vs immunotherapy-resistant tumors
Researchers at Tel Aviv University (TAU) can add to that list their important discovery of a cancer mechanism that has been shown to prevent the immune system from attacking tumors.
Israeli researchers measure interaction between immune cells and cancer cells
Technion scientists predict the efficacy of novel therapies in cancer
Israeli cancer breakthrough says which patients should get immunotherapy
Israeli researchers develop AI machine-learning tool for cancer therapy
Their discovery is significant because it eliminates the need to compare the RNA from the tumor to DNA from healthy cells.
UVA Cancer Center discovers immunotherapy that could cure types of brain cancer
CAR T-cell immunotherapy has been successful in tackling blood cancers but not solid tumors.
Clinical trial sees rectal cancer put into remission for all participants - report
One of the paper's authors said that he "believes this is the first time this has happened in the history of cancer.”
Cancers hurt, starve themselves to trick immune system, new study finds
To avoid the immune system, melanoma breaks down the amino acid tryptophan, stopping cells from properly functioning, but the cancer cells are able to do so despite lacking tryptophan themselves.
Jerusalem-based firm starts clinical trials for cancer treatment
The study will be conducted at multiple leading sites in the United States under a clinical collaboration with Roche, and is expected to attract 115 patients.
Weizmann Institute’s new technology may help treat cancer
This new method allows scientists to draw finer distinctions between cell subtypes and activities, which may be crucial when it comes to fighting cancer.
At-risk coronavirus patients can be identified in advance - study
The study focused on collecting information and samples from hospitalized COVID-19 patients to create a detailed profile of the immune response and to compare their different immune responses.
Sheba launches world's first ‘reversed personalized medicine’ cancer trial
Patients will be ‘modified’ to better respond to immunotherapy drugs
Israeli firm ready to assist coronavirus victims with novel drug
The innovative therapy is based on the research of Prof. Dror Mevorach, a senior physician from Hadassah-Hebrew University Hospital.
Israeli algorithm may predict if cancer patients will respond to treatment
It could also spare patients from undue suffering, since immunotherapy treatments can trigger severe auto-immune reactions.
